Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline UpdateJ. Clin. Oncol 2021 Jul 29;[EPub Ahead of Print], B Moy, RB Rumble, SE Come, NE Davidson, A Di Leo, JR Gralow, GN Hortobagyi, D Yee, IE Smith, M Chavez-MacGregor, R Nanda, HL McArthur, L Spring, KE Reeder-Hayes, KJ Ruddy, PS Unger, S Vinayak, WJ Irvin, A Armaghani, MA Danso, N Dickson, SS Turner, CL Perkins, LA Carey
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.